US Patent:
20110117210, May 19, 2011
Inventors:
Andrey Ugolkov - Buffalo Grove IL, US
International Classification:
A61K 33/30
A61P 35/00
A61K 31/315
Abstract:
The present invention is a non-topical method of therapeutically treating human cancer patients which comprises an administration of an anti-cancer medicament comprising at least one simple organic or inorganic salt of zinc in at least a minimally effective concentration to suppress malignant tumor growth and induce tumor regression in-vivo. Administration can be performed by oral, parenteral, and/or body cavity routings; and the therapeutic treatment method is effective for the treatment of a diverse range of primary human cancers and metastatic diseases.